Evidence map›Paper›PMID 34336088›Full record

ArticleOxidative medicine and cellular longevity2021

Carbon Monoxide-Releasing Molecule-2 Ameliorates Particulate Matter-Induced Aorta Inflammation via Toll-Like Receptor/NADPH Oxidase/ROS/NF-

Thi Thuy Tien Vo, Chien-Yi Hsu, Yinshen Wee, Yuh-Lien Chen, Hsin-Chung Cheng, Ching-Zong Wu, Wei-Ning Lin, I-Ta Lee

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Thi Thuy Tien VoSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
Chien-Yi HsuDivision of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.
Yinshen WeeDepartment of Pathology, University of Utah, Salt Lake City, UT, USA.
Yuh-Lien ChenDepartment of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Hsin-Chung ChengSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
Ching-Zong WuSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
Wei-Ning LinGraduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City, Taiwan.
I-Ta LeeSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-8451-0280
Taipei Medical University Hospital · TWTaipei Medical University · TWFu Jen Catholic University · TWNational Taiwan University · TWUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Particulate matter (PM), a major air pollutant, may be associated with adverse cardiovascular effects. Reactive oxygen species- (ROS-) dependent proinflammatory cytokine production, such as interleukin-6 (IL-6), is a possible underlying mechanism. Carbon monoxide- (CO-) releasing molecule-2 (CORM-2) which liberates exogenous CO can exert many beneficial effects, particularly anti-inflammation and antioxidant effects. The purpose of this study was to explore the protective effects and underpinning mechanisms of CORM-2 on PM-induced aorta inflammation. Here, human aortic vascular smooth muscle cells (HASMCs) were utilized as

Indexed as

AnimalsAortaHumansInflammationInterleukin-6MaleMiceNADPH OxidasesOrganometallic CompoundsReactive Oxygen SpeciesInterleukin-6NADPH OxidasesOrganometallic CompoundsReactive Oxygen Speciestricarbonyldichlororuthenium (II) dimer

Identifiers

PMID34336088
PMCPMC8292097
OpenAlexW3181035061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.